Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Hypertension. 2019 Sep 23;74(5):1113–1123. doi: 10.1161/HYPERTENSIONAHA.119.13469

Table 1:

General characteristics of each group at 6 weeks (A, prior to treatment, (n=7/group) and at 14 weeks (B, 8 weeks post-treatment, n=6–7/group).

1A Normal CKD CKD ELP-VEGF

Body weight (kg) 48.3 ± 5.6 49.4 ± 1.7 43.3 ± 3.3
Mean arterial pressure (mm Hg) 101 ± 5.3 128.7 ± 9.8* 137.7 ± 10.8*
Renal artery stenosis (%) 0 66.7 ± 2.9* 70.2 ± 3.6*
Tissue perfusion (mL/min/cc tissue) 4.4 ± 0.2 3.7 ± 0.2* 3.3 ± 0.3*
RVR (mm Hg/mL per min) 0.21 ± 0.03 0.29 ± 0.05* 0.44 ± 0.03*
Cortical volume (cc) 198.1 ± 13.3 127.0 ± 6.0* 145.2 ± 6.9*
Medullary volume (cc) 62.36 ± 1.7 46.5 ± 2.6* 44.2 ± 4.4*

1B Normal CKD CKD ELP-VEGF

Body Weight (kg) 62.3 ± 1.4 68 ± 2.1 62.2 ± 3.9
Mean arterial pressure (mm Hg) 106 ± 2.8 132.1 ± 1.9* 124.0 ± 4.3*
Tissue perfusion (mL/min/cm3 tissue) 4.7 ± 0.2 4.1 ± 0.2* 4.4 ± 0.5
RVR (mm Hg/mL per min) 0.11 ± 0.4 0.28 ± 0.02 0.23 ± 0.02*
Cortical volume (cm3) 210.9 ± 6.3 137.7 ± 5.2* 167.6 ± 15.8*^
Medullary volume (cm3) 57.5 ± 4.8 48.2 ± 3.2* 55.4 ± 5.1^

Values are expressed as mean ± SEM. Renal volume is presented as the sum of cortical or medullary area for both kidneys. RVR: Renal vascular resistance

*

p < 0.05 vs normal

p < 0.05 vs untreated CKD at 14 weeks

^

p < 0.05 vs 6 weeks (Table 1A).